During the past decade, Theagenion Anticancer Hospital of Thessaloniki conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 10 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 8 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Theagenion Anticancer Hospital of Thessaloniki" #1 sponsor was "Hellenic Oncology Research Group" with 14 trials, followed by "Amgen" with 8 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Celgene" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Theagenion Anticancer Hospital of Thessaloniki" #1 collaborator was "University Hospital of Crete" with 12 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Theagenion Anticancer Hospital of Thessaloniki" are "Multiple Myeloma" (13 trials), "Non Small Cell Lung Cancer" (6 trials), "Non-small-cell Lung Cancer" (4 trials), "Relapsed or Refractory Multiple Myeloma" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Theagenion Anticancer Hospital of Thessaloniki" in a lesser frequency.

Most popular intervention types in "Theagenion Anticancer Hospital of Thessaloniki" are "Drug" (50 trials), "Other" (3 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (12 trials), "Dexamethasone" (11 trials), "Placebo" (8 trials), "Pomalidomide" (8 trials) and "Gemcitabine" (7 trials). Other intervention names were less common.

The vast majority of trials in "Theagenion Anticancer Hospital of Thessaloniki" are 52 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Theagenion Anticancer Hospital of Thessaloniki". 2 are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Theagenion Anticancer Hospital of Thessaloniki, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Theagenion Anticancer Hospital of Thessaloniki, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".